MYC and chronic myelogenous leukemia, BCR-ABL1 positive: For example, as one of the most upregulated DE-miRNA targets, altered expression of myc may affect the expansion of pro-B cells (52) or the differentiation of HSC or CML to erythroid cells (53–55).